§FMCSR.com
Historical textIn force on Oct. 1, 2003Source: annual CFR editions 2001–2011

§ 382.213 Controlled substances use.

Wording in the annual edition revised as of Oct. 1, 2001, superseded by the 2012 annual edition.

govinfo, 2003 edition ↗
Before Jan. 1, 2017 the record is one snapshot per annual CFR edition, revised as of October 1. This is the 2003 edition's wording. An amendment that took effect between Oct. 1, 2003 and Oct. 1, 2003 would not appear until the next edition, so check the citations below and the Federal Register for exact effective dates.

(a) No driver shall report for duty or remain on duty requiring the performance of safety-sensitive functions when the driver uses any controlled substance, except when the use is pursuant to the instructions of a licensed medical practitioner, as defined in § 382.107, who has advised the driver that the substance will not adversely affect the driver's ability to safely operate a commercial motor vehicle.

(b) No employer having actual knowledge that a driver has used a controlled substance shall permit the driver to perform or continue to perform a safety-sensitive function.

(c) An employer may require a driver to inform the employer of any therapeutic drug use.

Amendment history

4 distinct wordings on file since Oct. 1, 1996
  1. [77 FR 4483, Jan. 30, 2012, as amended at 88 FR 80180, Nov. 17, 2023]
  2. [77 FR 4483, Jan. 30, 2012]
  3. Oct. 1, 2001 → Oct. 1, 2012annual editions 2001–2011diff vs. previousviewing
  4. Oct. 1, 1996 → Oct. 1, 2001annual editions 1996–2000

A new entry appears whenever the regulatory words change between government snapshots. Day-precise from the eCFR (2017 onward); before that, one snapshot per annual CFR edition (revised as of October 1). Bracketed citations are the Federal Register history printed with the section.